Literature DB >> 1759502

Internal image (Ab2 beta) anti-idiotype vaccines. Theoretical and practical aspects.

D C Poskitt1, M J Jean-Francois, S Turnbull, L Macdonald, D Yasmeen.   

Abstract

Anti-idiotype antibodies that carry an internal image of an antigen epitope (Ab2 beta antibodies) can be used in vaccine preparations to favourably manipulate the immune network. These vaccines have been shown to induce protective immunity in animals that have not been intentionally exposed to the native antigen epitope. This review attempts to define certain theoretical and practical aspects of immunological network manipulations and their relevance to Ab2 beta internal image anti-idiotype antibody vaccine design.

Mesh:

Substances:

Year:  1991        PMID: 1759502     DOI: 10.1016/0264-410x(91)90215-r

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Anti-idiotypic mimicry of a neutralizing epitope on the glycoprotein B complex of human cytomegalovirus.

Authors:  E S Tackaberry; J Hamel; Y Larose; B R Brodeur
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

2.  Crystal structure of an idiotype-anti-idiotype Fab complex.

Authors:  N Ban; C Escobar; R Garcia; K Hasel; J Day; A Greenwood; A McPherson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

3.  Production and characterization of rabbit anti-idiotypic antibodies directed against a murine monoclonal anti-B. abortus antibody.

Authors:  R Adone; F Ciuchini; R Bianchi; G Piccininno; C Pistoia
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

Review 4.  Methods for improving the immunogenicity and efficacy of cancer vaccines.

Authors:  Lorenzo Pilla; Soldano Ferrone; Cristina Maccalli
Journal:  Expert Opin Biol Ther       Date:  2018-06-17       Impact factor: 4.388

5.  Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements.

Authors:  Maha Z Ladjemi
Journal:  Front Oncol       Date:  2012-11-06       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.